[EN] NEW ISOINDOLINONE SUBSTITUTED INDOLES AND DERIVATIVES AS RAS INHIBITORS [FR] NOUVEAUX INDOLES ET DÉRIVÉS D'ISOINDOLINONE SUBSTITUÉS EN TANT QU'INHIBITEURS DE RAS
NEW ISOINDOLINONE SUBSTITUTED INDOLES AND DERIVATIVES AS RAS INHIBITORS
申请人:Boehringer Ingelheim International GmbH
公开号:US20220144810A1
公开(公告)日:2022-05-12
The present invention relates to new isoindolinone or isobenzofuranone substituted indoles and derivatives of formula (I) wherein the groups R
1
to R
7
, R
10
and n have the meanings given in the claims and specification, their use as inhibitors of RAS-family proteins and their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases.
[EN] NEW ISOINDOLINONE SUBSTITUTED INDOLES AND DERIVATIVES AS RAS INHIBITORS<br/>[FR] NOUVEAUX INDOLES ET DÉRIVÉS D'ISOINDOLINONE SUBSTITUÉS EN TANT QU'INHIBITEURS DE RAS
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2020173935A1
公开(公告)日:2020-09-03
-The present invention relates to new isoindolinone or isobenzofuranone substituted indoles and derivatives of formula (I) wherein the groups R1 to R7, R10 and n have the meanings given in the claims and specification, their use as inhibitors of RAS-family proteins and their use as medicaments, especially as agents for treatment and/or prevention of oncological diseases.